Symeres (previously MercachemSyncom) is a merger of Mercachem and Syncom, two of the leading European drug discovery Contract Research Organizations (CRO). It has operations in Nijmegen and Groningen, the Netherlands and Prague, Czech Republic. The group is the premier European mid-sized CRO offering innovative best-in-class chemistry solutions and has many large pharma and biotech companies as their clients.
Gilde Healthcare and its co-investor PGGM intend to support further M&A growth as well as the expansion of the current locations.
Location: Netherlands, Gelderland, Nijmegen
Employees: 201-500
Founded date: 1987
Investors 2
| Date | Name | Website |
| - | Gilde Heal... | gildehealt... |
| - | Keensight ... | keensightc... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 27.10.2022 | Netherlands-based Symeres acquires Exemplify Biopharma | Nijmegen, Netherlands-based global drug discovery company, Symeres acquired Exemplify Biopharma. The... | vcbay.news... |
| 26.10.2022 | Symeres Acquires Exemplify BioPharma | Symeres, a Nijmegen, Netherlands-based global drug discovery company, acquired Exemplify BioPharma, ... | finsmes.co... |